MEF2C-induced chemotherapy resistance could be explained partially by observations from studies in T-ALL have denoted that MEF2C can block BCL2-regulated apoptosis and act as a regulator of cell proliferation [7, 29]. The gene discussed is MEF2C; the disease is acute lymphoblastic leukemia.